There is another anti-resorptive agent called denusamab (Prolia) that is approved for postmenopausal osteoporosis.
Kukho enye into elwa nokufunxwa kwakhona ebizwa ngokuba yi-denusamab (Prolia) evunyiweyo ukuba isetyenziswe ngabantu asele beyekile ukuya exesheni abanesifo sobuthathaka nokuba qoboqobo kwamathambo.